[Management of severe sepsis using a Cytokin-adsorber]

Khosrow Siamak Houschyar; Susanne Rein; Kristian Weissenberg; Dominik Duscher; Hubertus Maria Philipps; Ina Nietzschmann; Torsten Schulz; Frank Siemers

doi:10.1007/s00113-017-0450-y

[Management of severe sepsis using a Cytokin-adsorber]

Unfallchirurg. 2018 Feb;121(2):174-178. doi: 10.1007/s00113-017-0450-y.

[Article in German]

Authors

Khosrow Siamak Houschyar¹, Susanne Rein², Kristian Weissenberg², Dominik Duscher³, Hubertus Maria Philipps², Ina Nietzschmann², Torsten Schulz², Frank Siemers²

Affiliations

¹ Plastic and Reconstructive Surgery, BG Klinikum Bergmannstrost Halle, Merseburger Str.165, 06112, Halle, Deutschland. Khosrow-Houschyar@gmx.de.
² Plastic and Reconstructive Surgery, BG Klinikum Bergmannstrost Halle, Merseburger Str.165, 06112, Halle, Deutschland.
³ Klinikum rechts der Isar, München, Deutschland.

PMID: 29247319
DOI: 10.1007/s00113-017-0450-y

Abstract

Based on a representative case, which was treated in our center for severe burn injuries, the severity of the Waterhouse-Friderichsen syndrome and the complexity of the prolonged course of treatment are illustrated. Special attention is focused on the new treatment paradigm using the CytoSorb® adsorber.

Keywords: CytoSorb®; Cytokin; Disseminated intravascular coagulation; Sepsis; Waterhouse-Friderichsen Syndrome.

Publication types

Case Reports

MeSH terms

Amputation, Surgical
Burns / blood
Burns / therapy*
Cytokines / blood*
Disseminated Intravascular Coagulation / blood
Disseminated Intravascular Coagulation / therapy
Hemadsorption*
Humans
Interleukin-10 / blood
Interleukin-6 / blood
Male
Middle Aged
Pneumococcal Infections / blood
Pneumococcal Infections / therapy*
Risk Factors
Sepsis / blood
Sepsis / therapy*
Splenectomy
Stevens-Johnson Syndrome / blood
Stevens-Johnson Syndrome / therapy*
Waterhouse-Friderichsen Syndrome / blood
Waterhouse-Friderichsen Syndrome / therapy*

Substances

Cytokines
IL10 protein, human
IL6 protein, human
Interleukin-6
Interleukin-10